Pfizer, Inc. (PFE) CEO Albert Bourla on Q1 2022 Results - Ea

Pfizer, Inc. (NYSE:NYSE:PFE) Q1 2022 Earnings Conference Call May 03, 2022, 10:00 ET Company Participants Christopher Stevo - SVP & Chief IR Officer Albert Bourla - Chairman & CEO...

Related Keywords

United States , Israel , Italy , China , Russia , Quebec , Canada , Ukraine , Italian , Russian , Russians , Robyn Karnauskas , Frank Damelio , Andrew Baum , Albert Bourla , Tim Anderson , Chris Stevo , Evan Seigerman , Carter Gould , William Pao , David Denton , Angela Hwang , Terence Flynn , Doug Lankler , Kerry Holford , Geoff Meacham , Alex Hammond , Steve Scala , America Merrill Lynch , Christopher Schott , Aamir Malik , Christopher Stevo , Mikael Dolsten , Louise Chen , Chris Schott , Stephen Scala , Timothy Anderson , Colin Bristow , Mohit Bansal , Morgan Stanley , Development Officer , Company Participants , Pfizer , Worldwide Research , Jpmorgan Chase Co , Biopharmaceuticals Group , Pfizer Inc , Wolfe Research , Barclays , Wells Fargo , Barclays Bank , Cantor Fitzgerald Co , Patient Assistance Program , National Panoramic Study , Pfizer Biopharmaceuticals Group , Citigroup , Conference Call May , Scientific Officer , America Merrill , First Quarter , Senior Vice President , Chief Investor Relations , Frankd Amelio , Group President , Chief Business , Innovation Officer , General Counsel , Chief Development , Investor Relations , Risk Factors , Emergency Use Authorization , Conditional Market Authorization , While Pfizer , Executive Vice President , Chief Financial Officer , Executive Vice , Annual Pharmaceutical Innovation , Invention Index , Total Rd Productivity , New Drug Application , Vitiligo Area Severity Indexes , Fast Track Designation , European Medicines Agency , Medicinal Products , Human Use , Prime Designation , Vamil Divan , Patient Assistance , Latin America ,